Loading chat...
MI HB5350
Bill
Status
11/14/2023
Primary Sponsor
Alabas Farhat
Click for details
AI Summary
-
Prohibits drug manufacturers from denying, conditioning, or limiting 340B pricing on drugs purchased by 340B entities, including drugs dispensed or administered through contract pharmacy arrangements.
-
Prevents manufacturers from prohibiting pharmacies from contracting with 340B entities or denying them 340B pricing and drug access based on their relationship with a 340B covered entity.
-
Defines "340B entity" as a covered entity under 42 USC 256b, which establishes the federal 340B drug pricing program for eligible health care organizations and pharmacies.
Legislative Description
Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c.
State agencies (existing): licensing and regulatory affairs
Last Action
Per Rule 41 Referred To Committee On Insurance And Financial Services
1/10/2024